Hair Growth Treatment
About 3.5 years ago the Sanford Burnham Prebys medical research institute released an article that received major attention in the hair seeker community and in the mainstream media. SBP researcher Alexey Terskikh PhD had just published a peer reviewed article detailing his work turning human embryonic stem cells (hESCs) into hair-producing dermal papillae cells. It…
New Beauty, a magazine covering the female aesthetics industry, has released a print article featuring “hair loss solutions.” The article contains quotes and information from Dr. George Cotsarelis, RiverTown Therapeutics, and Histogen. The Brotzu Lotion is also mentioned, though with information already known. Setipiprant For Females In the article, Dr. Cotsarelis shares that his lab…
I have just received an email from a representative of MAX BioPharma, a biotechnology company based in Santa Monica CA, which directed me to the company’s crowdfunding campaign for a hair loss experiment. After taking a quick review of the company and the campaign, I’ve decided it’s worthwhile to share here. About The Company MAX BioPharma…
Tissue regeneration company PolarityTE has recently been featured in the media for positive results from its SkinTE product in a severe burn patient case. The company announced the news formally today via press release. To recap PolarityTE’s recent developments, the company has been rolling out its SkinTE product for skin/wound healing in select hospitals and…
More news of progress is coming from Histogen and it’s going to raise a few eyebrows. This time, founder Gail Naughton gives details about the HSC660 trial in women and a late stage trial for men in Mexico. While browsing an article featuring Histogen on the San Diego Union Tribune website, I discovered some new…
Follicle Thought has received a brief update to share regarding the progress of the highly anticipated company Shiseido. On July 4th I sent a tweet to Replicel CEO Lee Buckler asking him when he thought we would hear an announcement from Shiseido pertaining to their trial of RCH-01. His response is shown below. As you…
I’m pleased to share with you all a startup which is a little bit “outside the box” from the usual companies you’d see on Follicle Thought. Today’s topic of interest, Birch BioMed, is based in Vancouver, Canada and was birthed on the campus of the University of British Columbia. The company’s prize clinical candidate is…
SCM Lifescience is a biotechnology company based in South Korea with a focus on adult stem cell therapeutics. The company had caught my eye several months ago when I read about its plans to develop a stem-cell derived product for hair growth. Since then, SCM seems to be making progress on that path. SCM Lifescience…
The New Yorker Magazine published an article this morning on the truly “age old quest” of curing hair loss. The article, written by Amos Barshad, is not your typical mainstream media wrap on baldness and its treatment horizon. Amos spoke to a large pool of the hair growth industry companies and household names. Featured in…
Today, Follicum announced their phase 2a trial of FOL-005 for the scalp is fully recruited. The trial consists of injections of Follicum’s modified peptide, FOL-005, over a three month period. This trial design is supportive for a data readout by year’s end, as enrollment has been completed while still in June. CEO of Follicum, Jan…